[COVID-19] Delhi High Court asks Centre, Delhi govt to ensure transparent, efficient, timely allocation of Tocilizumab

Roche India informed the Court that in view of the COVID-19 situation in India, it has decided on its own to immediately supply 10,000 doses of Tocilizumab 400 MG, free of cost.
[COVID-19] Delhi High Court asks Centre, Delhi govt to ensure transparent, efficient, timely allocation of Tocilizumab
Delhi High Court

The Delhi High Court has asked the Central government and the Delhi government to take immediate steps to ensure that COVID-19 drug Tocilizumab is allocated in a transparent and timely manner for the benefit of patients in need (Dharmendra Kumar v. GNCTD).

Want to read the full story?

We’re glad you’re enjoying this story. Subscribe to any of our plans to continue reading the story.

Already have an account? Sign In

Related Stories

No stories found.